Literature DB >> 11450325

Hypertensive emergencies.

W J Elliott1.   

Abstract

In summary, patients presenting with a true hypertensive emergency should be diagnosed quickly and promptly started on effective parenteral therapy (typically nitroprusside 0.5 microgram/kg/min or fenoldopam 0.1 microgram/kg/min) in an intensive care unit. Blood pressure should be reduced about 25% gradually over 2 to 3 hours. Oral antihypertensive therapy (often with an immediate-release calcium antagonist) can be instituted after 6 to 12 hours of parenteral therapy, and consideration should be given to secondary causes of hypertension after transfer out of the intensive care unit. Because of advances in antihypertensive therapy and management, "malignant hypertension" should be truly malignant no longer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11450325     DOI: 10.1016/s0749-0704(05)70176-7

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  4 in total

Review 1.  Management of hypertension emergencies.

Authors:  William J Elliott
Journal:  Curr Hypertens Rep       Date:  2003-12       Impact factor: 5.369

Review 2.  Treatment of hypertensive urgencies and emergencies.

Authors:  C Venkata S Ram; Russell L Silverstein
Journal:  Curr Hypertens Rep       Date:  2009-10       Impact factor: 5.369

3.  Patients with hypertensive crises who are admitted to a coronary care unit: clinical characteristics and outcomes.

Authors:  Héctor González Pacheco; Neisser Morales Victorino; Juan Pablo Núñez Urquiza; Alfredo Altamirano Castillo; Ursulo Juárez Herrera; Alexandra Arias Mendoza; Francisco Azar Manzur; Jose Luis Briseño de la Cruz; Carlos Martínez Sánchez
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-01-09       Impact factor: 3.738

Review 4.  Clinical features and management of selected hypertensive emergencies.

Authors:  William J Elliott
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-10       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.